Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1565.2000 1.20 (0.08%)
NSE Aug 18, 2025 15:31 PM
Volume: 1.8M
 

logo
Cipla Ltd.
29 Jan 2025
1565.20
0.08%
buy
by Axis Direct
Target: 1700 | Upside : 8.6%
Axis Direct
We maintain our BUY recommendation with a target price of Rs 1,700/share.
 
Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
More from Cipla Ltd.
Recommended
IPO Wave Continues: Ten New Issues and Four Listings Lined Up This Week
| 18 Aug 2025, 04:58PM
Market closes higher, Ahluwalia Contracts' net profit misses Forecaster estimates by 14% in Q1
Trendlyne Marketwatch | 18 Aug 2025, 04:00PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022